Molina Healthcare, Inc.
MOH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $40,650,000 | $34,072,000 | $31,974,000 | $27,771,000 |
| % Growth | 19.3% | 6.6% | 15.1% | – |
| Cost of Goods Sold | $35,914,000 | $29,738,000 | $28,048,000 | $24,491,000 |
| Gross Profit | $4,736,000 | $4,334,000 | $3,926,000 | $3,280,000 |
| % Margin | 11.7% | 12.7% | 12.3% | 11.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,743,000 | $2,462,000 | $2,311,000 | $2,068,000 |
| SG&A Expenses | $2,743,000 | $2,462,000 | $2,311,000 | $2,068,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $286,000 | $299,000 | $442,000 | $192,000 |
| Operating Expenses | $3,029,000 | $2,761,000 | $2,753,000 | $2,260,000 |
| Operating Income | $1,707,000 | $1,573,000 | $1,173,000 | $1,020,000 |
| % Margin | 4.2% | 4.6% | 3.7% | 3.7% |
| Other Income/Exp. Net | -$118,000 | -$109,000 | -$110,000 | -$145,000 |
| Pre-Tax Income | $1,589,000 | $1,464,000 | $1,063,000 | $875,000 |
| Tax Expense | $410,000 | $373,000 | $271,000 | $216,000 |
| Net Income | $1,179,000 | $1,091,000 | $792,000 | $659,000 |
| % Margin | 2.9% | 3.2% | 2.5% | 2.4% |
| EPS | 20.52 | 18.71 | 13.7 | 11.4 |
| % Growth | 9.7% | 36.6% | 20.2% | – |
| EPS Diluted | 20.42 | 18.78 | 13.54 | 11.25 |
| Weighted Avg Shares Out | 57,400 | 58,100 | 57,800 | 57,800 |
| Weighted Avg Shares Out Dil | 57,700 | 58,100 | 58,500 | 58,600 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $118,000 | $109,000 | $110,000 | $120,000 |
| Depreciation & Amortization | $186,000 | $171,000 | $176,000 | $131,000 |
| EBITDA | $1,893,000 | $1,744,000 | $1,349,000 | $1,126,000 |
| % Margin | 4.7% | 5.1% | 4.2% | 4.1% |